Nuala Moran

A British pharmaceutical distributor, Beckpharma Ltd., said it licensed two Cuban healthcare products to sell in Europe as part of a broader effort for trade links.

It has been six years since a French biotech company made a stock market debut – and now two, BioAlliance and ExonHit, are doing so. Is the European market reawakening?

With licensing and collaboration now the lifeblood of the drug industry, the annual BIO-Europe get-together was focused on partnering. Nuala Moran was there.

Nuala Moran takes a behind-the-scenes look at the strategies involved in Europe's biggest patent victory in years.

After the initial hype, the long haul through clinical development and the inevitable pitfalls, gene therapy is on the verge of becoming a commercial reality in Europe - ahead of the US.

Oxford Genome licenses a genomic database with a long pedigree to Belgium’s UCB

Nuala’s Moran’s roundup of news and views in the management of intellectual assets focuses on how to keep alliances happy

Philips is seeking to boost adoption of its clock-less integrated circuit technology, offering it at a knockdown price to universities and research institutions.

Nuala’s Moran’s roundup of news and views in the management of intellectual assets Helpdesk